You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Ukraine Patent: 127863


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 127863

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 16, 2036 Loxo Oncol JAYPIRCA pirtobrutinib
⤷  Start Trial Dec 16, 2036 Loxo Oncol JAYPIRCA pirtobrutinib
⤷  Start Trial Dec 16, 2036 Loxo Oncol JAYPIRCA pirtobrutinib
⤷  Start Trial Dec 16, 2036 Loxo Oncol JAYPIRCA pirtobrutinib
⤷  Start Trial Dec 16, 2036 Loxo Oncol JAYPIRCA pirtobrutinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Analysis of Ukraine Patent UA127863

Last updated: February 27, 2026

What is the scope of patent UA127863?

Patent UA127863 pertains to a pharmaceutical composition or method. The patent claims define its scope, primarily covering specific formulations, compositions, or methods of use. The broadest claim likely covers a class of compounds or formulations with particular structural features or therapeutic indications.

Patent Claims Overview

  • Claim 1: Typically, an independent claim outlining the core inventive concept—a specific composition, method, or compound.
  • Dependent Claims: Modulate claim 1 by adding particular features, such as specific concentrations, excipients, or delivery methods.

The exact claims need review for precise scope but generally cover:

  • Active ingredient(s) with defined chemical structure.
  • Formulation specifics—e.g., dosage forms, excipient combinations.
  • Therapeutic methods using the composition.

Key features likely protected:

  • The chemical class or specific molecule.
  • Specific dose ranges.
  • Application in treating particular medical conditions.

How do the claims compare with existing patents?

  • The claims are narrower if they focus on a specific compound or formulation.
  • Broader claims might encompass a class of compounds or therapeutic indications.
  • Overlap with international patents depends on similar chemical classes or therapeutic areas.

Patent Landscape Analysis

Filing and Priority Dates

  • Filing date: Exact date needed—likely in recent years based on the patent number.
  • Priority date: Critical for assessing novelty.

Patent Family and International Status

  • Local patent family covering Ukraine only, common for regional filings.
  • Investigate potential family members filed in the European Patent Office (EPO), Russia, or other jurisdictions to understand global protection.

Related Patents and Competitors

  • Similar patents in the same therapeutic space indicate competitive landscape.
  • Patent searches using databases like EPO, WIPO, and USPTO reveal relevant prior art.

Patent Validity and Maintenance

  • The patent is typically valid for 20 years from the filing date subject to maintenance payments.
  • Status check through Ukrainian patent office databases ensures the patent is active.

Prior Art and Freedom-to-Operate

  • Existing patents on similar molecules or formulations may limit commercialization.
  • Infringement risk if competing patents cover similar inventions.

Strategic Considerations

  • The patent’s narrow or broad claims will influence licensing, litigation, and R&D strategies.
  • Whether the patent covers a core molecule or a secondary formulation impacts market exclusivity.
  • Patent term extensions are generally unavailable in Ukraine.

Summary Table

Aspect Details
Patent Number UA127863
Filing Date Exact date needed
Priority Date Same as filing date or earlier based on priority claims
Patent Status Active (assuming maintenance payments are up to date)
Patent Term 20 years from filing date
Key Claims Likely covers a specific chemical compound or formulation
Related Patents Search needed for family members in other jurisdictions
Competitors Firms working in similar therapeutic spaces

Citations

  1. Ukrainian Patent Office. (n.d.). Patent search database.
  2. WIPO. (2022). Worldwide patent search. Retrieved from https://patentscope.wipo.int
  3. European Patent Office. (n.d.). Patent family and legal status database.

Key Takeaways

  • UA127863 covers a specific drug composition or method, with claims tailored to a particular chemical or formulation.
  • The patent’s scope depends on the breadth of the claims, with potential overlaps in similar therapeutic classes.
  • The patent landscape includes regional and possibly international filings, with ongoing relevance for R&D and commercialization strategies.
  • Patent validity remains subject to maintenance payments; thorough legal status review is recommended.
  • Competitive positioning depends on the similarity of claims with prior art and existing patents.

FAQs

Q1: When was patent UA127863 filed?
A1: The exact filing date requires consultation of official Ukrainian patent records.

Q2: Does UA127863 cover any specific therapeutic indications?
A2: Likely yes; claims may specify use in certain diseases or conditions based on the patent document.

Q3: Is UA127863 part of an international patent family?
A3: This requires searching WIPO or EPO databases for family members in other jurisdictions.

Q4: Can the patent be enforced in Ukraine?
A4: Yes, if active and maintained; enforcement depends on legal proceedings within Ukrainian courts.

Q5: What is the scope of claims?
A5: Likely covers a particular chemical compound or formulation, precise scope in the patent document.

References

[1] Ukrainian Patent Office. (n.d.). Patent search database.
[2] WIPO. (2022). Patent scope. https://patentscope.wipo.int
[3] European Patent Office. (n.d.). Patent family and legal status.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.